Posted by choysun > 1 day ago | Report Abuse

Reversal time :)
-------------------------------------------

Good price action observation @Choysun. Ever considered to become a career professional cha cha dancer? :p

Lets wait for presentation of full lucidity results at CTAD conference. Taurx session on 30/11 @11.30am San Francisco time.

Not bad. Quite resilient today. Professional cha cha dancers like to watch price action especially late afternoon onwards.

There are very little officially declared shorts in GentB for a long time. I think most of the selling recently has been done by FFs. When so many people are bearish and on one side of the boat, the opposite may happen in a sudden and spark a technical rebound.

Inflation took so long to really take off, 14 years of ZIRP and non-stop QE money printing reaching USD9T on Fed's balance sheet. The inflation genie is out of the bottle now, not easy to get it back into the bottle.

I believe fed is going to hike 0.75% on Nov based on what Powell said on post FOMC conference last week especially the Q&A part.

Daily Trading Participation
As at 23 September 2022
Participation Participation % Bought (RM Mil) Sold (RM Mil) Net (RM Mil)
Foreign 29.31% 352 571 -218

FF net sold -RM218m last Friday.

USD abt to breach 4.60 ringgit today.

FF net outflow was -rm193m on 21/9. Another -rm123m on 22/9. I think for 23/9 shd be over -rm100m. These are hot money, fair weather friends that will run away when bursa in trouble.

Today's selling exceptionally strong. Various levels of 500k buy q taken down easily by sellers. Hiong!

4.40 just cracked. Now gunning for 4.30???

Posted by BradonOoi > 21 seconds ago | Report Abuse
Panic sell. Seems like market is not optimistic over Genting getting Macau gaming license...
------------------------------------------------------------------

Macau licence application is not exactly a bad news. Pre-covid days Macau was the global number 1 gaming market. During bull market, this news could be greeted by a rally base on Macau licence theme play.

Strong selling more likely due to bear market's dominant downward force exerting itself, hence price moving lower and lower. Global stock indexes all red everywhere. There is little catalyst for the bulls to start coming in after very hawkish FED during FOMC post-conference. The average Fed members' forecast pivot rate is 4.6%. Some area of the economy may crack big time (especially highly indebted and stressed sectors/companies) and may evolve into another financial crisis some time down the road. FedEx and Ford already sounded warning bells on weak earnings forward. In summary, its a bear market.

New recent low..... strong sellers today. FF again?

Daily Trading Participation
21 September 2022
Participation Participation % Bought (RM Mil) Sold (RM Mil) Net (RM Mil)
Foreign 30.63% 411 604 -193

FF run road?

Posted by magellan > 1 hour ago | Report Abuse

DestinyL deja vu again, lol
-------------------------------------------

@Magellan, I am a big fan of yours. Recently saw a video abt you. Enjoy!

https://www.youtube.com/watch?v=4WsPTqcwLiA

Posted by WinSSP > 12 minutes ago | Report Abuse
that old fella pakai red underwear on his kepala again…no wonder kena bad luck! Hahaha
----------------------------------------------------------------------------------

Red underwear or not is secondary. Cha cha aunty can wear a few red underwears at once also but her cha cha dance still cannot make it.

Quick leh, any update abt your average entry price? Keke....

Post removed.Why?

Where is Sharefisher? That smart one knows when is bull market, when is a bear market. Short term entry price TA skill is not as important as knowing the primary direction of the stock market. In a bull market most of the stocks will go up, and in a bear market most of the stocks will go down.

cha cha aunty will check-in daily. But sometimes her posts will kena dementia, miraculously disappeared and deleted later on :p

Posted by MoneyMakers > 2 days ago | Report Abuse

Nice morning discount..go back to old house @ rm4.5++ pls
-------------------------------------------------------------------------------------

Aiyo failed contra punter @Dreammaker, strong support 4.50 just broken and you went in to buy? Support level now become resistance level, understand? Go and learn some technical analysis first!

Post removed.Why?

Attending AAIC only with exhibit booth. No presentation of full trial data.

TauRx is attending Alzheimer’s Association International Conference in San Diego, USA, from 31 July to 4 August.

The AAIC is held each year and attracts the world’s leading scientists, clinical researchers, early career investigators, clinicians, and the care community with the aim of sharing research discoveries that will lead to methods of prevention, treatment and improvements in the diagnosis of Alzheimer’s disease.

More information about the event can be found here

TauRx has a dedicated meeting room within the exhibition hall (Exhibitor Business Suite #E0), and we are looking forward to speaking to delegates about our work.

Check back in a few weeks to read our reflections after attending the event.

Gaming - Visitors Are Back, and Yields Are Attractive; O/W
Date: 2022-07-14
Firm: RHB-OSK
Stock: GENTING
Price Target: 6.37
Price Call: BUY
Last Price: 4.50
Upside/Downside:
+1.87 (41.56%)
OVERWEIGHT.

At Resorts World Genting (RWG), tourists and gamblers are back, which should fuel a meaningful sector earnings recovery in the coming quarters. While we think that gaming and non-gaming revenues, and number forecast operators’ (NFO) ticket sales should continue recovering towards pre-pandemic levels, we highlight that inflation may dampen consumers’ discretionary spending. Nevertheless, the casinos’ undemanding valuations of 6-8x FY23F EV/EBITDA and NFOs’ attractive yields of c.7% provide a defensive proposition amidst market uncertainty.

The return of tourists and gamblers. From our recent ground checks at RWG on a Wednesday afternoon, we found that hotel rooms are fully booked for the weekends. We were also pleasantly surprised by the large casino crowd on a Wednesday afternoon. As Malaysia’s and Singapore’s borders have reopened, we think that RWG and Resorts World Sentosa (RWS) are likely ramping up efforts to attract tourists from the region.

The casinos are beneficiaries of a weakening MYR, in our view. YTD, the USD has strengthened by c.6% against the MYR. With Genting Malaysia (GENM) typically earning 8-16% of its adjusted EBITDA from the US division (1Q22: 19%), and Genting (GENT) typically earning 6-10% of its adjusted EBITDA from the US (trailing 12-month average: 31%, 1Q22: 21%), the strengthening USD/MYR should translate into higher MYR earnings. As GENT's management is still ramping up the business at Resorts World Las Vegas (RWLV), its EBITDA contribution from the US should rise accordingly. A weaker MYR may also make Malaysia a more affordable tourist destination for foreign tourists, but we note that, historically, more than 80% of RWG's visitors are domestic tourists.

Inflation casts a shadow. May's inflation in most of GENT and GENM's operating markets – Malaysia (2.8%), the US (8.6%), the UK (9.1%), Singapore (5.6%) – have been higher than expected. Given the discretionary nature of casino and leisure spending, we think that potentially persistent and high inflation rates and, as such, weakened consumer spending power, could adversely impact GENM's gaming and non-gaming revenues, as well as GENT's leisure and hospitality businesses.

NFOs – slow recovery, but attractive yields. We gathered that ticket sales in 2Q22 were still at 70-80% of pre-pandemic levels – a sign of punters’ continued weakened financial conditions and reliance on illegal operators. While we think that inflation may drag on ticket sales, we highlight that Magnum offers a dividend yield of 6.7%, and Sports Toto (SPTOTO) offers 7.2%, which we think are attractive amidst market uncertainty.

Top Pick: GENT. GENT’s leisure and hospitality businesses should continue to recover with the on-going resumption in tourism activity. Its plantations and oil & gas units stand to benefit from elevated ASPs stemming from high commodity prices. Its 6.3x FY23F EV/EBITDA is attractive vs the regional peer average of 12x, and any additional value accretion from GENT’s 20%-owned TauRx Pharmaceuticals is a plus point. Among the NFOs, we prefer SPTOTO. Apart from its continued ticket sales recovery, we also like the growth exposure from its other segments, such as its UK motor dealership and hotel & gaming businesses in Berjaya Philippines. Key risks to the sector include a fluctuation in luck factor, changes in government policies, and a prolonged pandemic.

Source: RHB Securities Research - 14 Jul 2022

https://www.marketwatch.com/story/biogen-stops-clinical-trial-tracking-aduhelm-2022-06-24?siteid=yhoof2

https://finance.yahoo.com/news/athira-pharma-shares-fall-52-122145899.html

https://www.fiercepharma.com/pharma/bms-pfizer-merck-face-extreme-patent-exposure-all-have-financial-flexibility-ma-scores

A few weeks ago, TauRx attended the 35th Alzheimer Disease International Conference held at the Oval in London. With over 1,200 delegates at the 2022 conference, TauRx was proud to support the event as platinum sponsor.

With delegates from over 100 countries, this conference was a prime opportunity to reinforce the importance of tau as a target when developing a potential treatment for Alzheimer’s and to share the latest research from TauRx.

TauRx shared some preliminary information about its LUCIDITY study and welcomed the encouragement from panel members, of the symposium session. The panel discussion was chaired by Professor Serge Gauthier, with engaging discussion from Ms Paola Barbarino, ADI CEO, Dr Richard Stefanacci, Chief Medical Director Eversana and Dr Jefferey Cummings, University of Nevada, Research Professor of Brain Science.

Huge unmet need

Noted during the symposium was the fact LUCIDITY is one of the few trials which targets the tau pathology of Alzheimer’s.

Over 35 million people live with Alzheimer’s disease and many more have mild cognitive impairment and pre-clinical Alzheimer’s. By 2050, 135 million will have Alzheimer’s, it is a huge unmet medical need.

However, it was clear through the varied presentations, posters, and exhibition booths at ADI2022, that we must strive to include people living with dementia in corporate and research activities.

A voice must be given to people most affected by dementia, but we must also collectively strive to focus on education and diagnosis to irradicate the barriers to a timely diagnosis. This includes, as Kielan Arblaster from Alzheimer’s Society highlighted, the need to raise awareness of the value of a diagnosis and greater involvement of primary care providers.

Battling stigma

Throughout, a core theme of the wider conference was raising awareness of dementia to battle the stigma associated with the condition.

A universal agreement at the conference is that dementia doesn’t discriminate, and this is a huge unmet medical need. We must all work together to promote dementia awareness, within society and within our governments to ensure we build a stigma-free culture which encourages individuals to seek out a diagnosis and any support they need free from worry or fear.

A wide range of international case studies were presented to help outline the stages of dementia and Alzheimer’s care and policies in countries around the world. It was great to see examples of how together we can collectively raise awareness.

Fireside Chat

TauRx’s second session was a fireside chat with Dr Sonya Miller, Head of Medical Affairs and Medical Oversight Lead, and Dr Emer MacSweeney, CEO and Head of Re:Cognition Health, one of the largest providers of clinical trials in the UK for neurodegenerative conditions. Joining them were special guests Stanley, who lives with Alzheimer’s, and his son Martin.

Stanley took part in an early clinical trial and now continues to take the investigative medication as part of an extended access program. Initially overwhelmed by his father’s diagnosis, Martin explained he actively searched Google for information on what they could do and discovered clinical trials. Listening to the shared experience of Stanley taking part in a clinical trial with the support from an experienced clinician in the field was overwhelmingly positive.

Old cha cha aunty's posts also have dementia. Can suddenly disappear and forgotten also.

She forgot she started abusive posting first today. Now accusing others of abusive posts. So shameless.

Post removed.Why?

Post removed.Why?

Posted by WinSSP > 1 minute ago | Report Abuse

Apasal quote 5 days ago Makcik ATK? Basi la :p
--------------------------------------------------

You forgot you have dementia? What is your average entry price now? :)

Post removed.Why?

Posted by Keyman188 > 1 hour ago | Report Abuse

Amboi...what is happening now !!!...

Keyman188 still maintaining to see KLCI @ 13xx for this year (2022)...

wkwkwk...kekeke...hehehe...
--------------------------------------------------

Aiyo Amboi oldman your "see you at KLCI 13XX soon" prediction was wrong a few months back. KLCI shot up to 16XX, GenB shot up to 5.34. A lot of fellow Genting comrades huat and sold off already, now slowly getting back in.

Of course eventually KLCI will see 13XX. Bear market mah. A dead clock is also correct twice a day right? BTW it seems that "outside window" performing even worse relative to KLCI. Unless you have the foresight to short the "outside window" market..... but you have been encouraging people here to buy the "outside window" market.

Post removed.Why?

Post removed.Why?

Last fed meeting Powell already said 0.75% not in consideration. But he may give some hawkish projections etc. Fed cannot be fully responsible for high inflation, yet cannot crash the economy. How to control Putin to stop the war? How to stop all the sanctions against Putin? How to tell China dont lockdown it will worsen supply chain disruption? There is real supply shortage, no choice. Alternatively can hike the rates more, bankrupt the highly in debt USA, crash the economy to tame down the demand side. But this method going to end up worse.

Whether its 8.3% to 8.6% or 8.6% to 8.3%, it is still high inflation. Wait until 2023 Feb CPI data then the rate will auto drop because we are comparing CPI to the high base from Putin war Feb 2022 onwards. After 14 years of easy monetary policies by all the global central banks, Im surprise 2022 then inflation really starts to bite hard. We better be mentally prepared and get used to inflation going forward.

Post removed.Why?

Posted by anthonytkh > 42 minutes ago | Report Abuse

“All will fail their phase 3 trials”….. oh, ok Ang….
-------------------------------------------------------

Big names that have failed and / or repeatly failed in disease modifying AD phase 3 trials include Pfizer, JNJ, Eli Lilly, BMS, Roche, Biogen, etc

A lot of small but NASDAQ listed biotechs formerly in hype eventually won't work also. Axovant Science (now known as Sio Gene), Annovis, Cassava, Cortexyme, MC Immune, etc.

An effective disease modifying AD drug is so difficult to develop that even Pfizer gave up and shut down their AD research department a few years ago. Pfizer JV Eisai were the first to commercialise an AD drug called Aricept (now known as Donepezil as a generic drug).

Posted by MoneyMakers > 3 minutes ago | Report Abuse

Looks like AngTK still angry with me after humiliating him few months back

Talk like know everything but actually know nothing 1..apparently proving AngTK wrong he consider ‘personal public humiliation’ kikiki
---------------------------------------------------------

Aiyo failed contra punter dream makers dont come here and spell GERM as GEM abt yourself. When you heng heng didnt lose on your contra punting trades, how many % can you make?

LKT and ATK both have the astute investment skills and good foresight to bet big on Taurx. Chances of phase 3 trial success is 0.1% vs 99.9% and we can bet super big on the correct dark horse... its really not simple. Wake up la dream makers. We are talking abt 100 baggers return eventually.

Posted by anthonytkh > 26 minutes ago | Report Abuse

Ang, let’s just wait and see. I’m a Malaysian and of course I’d like a Malaysian company be involved in a successful treatment for AD (even if the Malaysian company is most famous for a “leisure drug” that have caused suicides)

Glaxo backs another company. There are 3 others currently in Ph2 trials. I think 2 of them are listed in Nasdaq
-----------------------------------------------------------------

All will fail their phase 3 trials. Spreading of misfolded Tau is the root and cause of AD. Even if competitors have some early stage of Tau research program, very difficult to be successful. The correct method is T.A.I = Tau Aggregate Inhibitor. There are good Tau which is essential for the functioning of brain. Some programs targeting the wrong tau, some using wrong method of application. Numerous Tau programs that has already failed. Not so simple. Lucidity's success is a cumulation of 35 years discovery, knowledge and extensive research.

Post removed.Why?

Posted by WinSSP > 42 minutes ago | Report Abuse

News directly from GB more reliable….
----------------------------------------------------------


These "news" are definitely not reliable. Kekeke......


Posted by Stocksafeplayer > Mar 19, 2021 4:25 PM | Report Abuse
Congrats.......
My average is 4.50....Super grateful aldy!!
-------------------------------
Posted by Stocksafeplayer > Apr 21, 2021 5:45 PM | Report Abuse
My average is 4.20....4.68 too expensive la
-------------------------------
Posted by Stocksafeplayer > Sep 1, 2021 4:31 PM | Report Abuse
Average 4.00…. at 5.05… already more than 250k profit on paper… heng ahh!
--------------------------------
Posted by shareinvestor888 > Jan 27, 2022 6:39 PM | Report Abuse
I bought GenB at 3.50…. Very happy….

MR TAN KONG HAN (a company director) acquired 73,000 shares at 4.730 on 30-May-2022.
MR TAN KONG HAN (a company director) acquired 27,000 shares at 4.680 on 30-May-2022.
--------------------------------------------------------------

This guy is Taurx director also. He must be confident of Taurx.

Posted by newbie2019 > 38 seconds ago | Report Abuse

ATK Sifu when are u entering? or what price will Sifu be entering?
----------------------------------------------------------------


I cannot say too much. Lone wolf trading style quietly come quietly go. FOMC starts tonight and I expect shorts to cover.

Current price is as if Lucidity trial failed. But I know the primary endpoints ADAS-COG = No Decline, ADCS-ADL= 67% slowdown.

Anyone can guess and tell me the valuation of Taurx?

Posted by Income > 27 minutes ago | Report Abuse

Oppa Gangnam style
---------------------------------------

GenB is a Cha Cha stock!

No need to wait for end of 12 month open label for approval submission. The main focus regulators look at is on the first 12 month randomised and blinded phase 3 trial.

No need to wait for drug commercialisation before IPO. Many biotechs in NASDAQ are still not in late stage phase 3 trial, let alone commercialisation stage. Since 99.9% of AD drugs fail at phase 3, Taurx IPO will not be cheap. Investors can buy with certainty with successful phase 3 trial result.

A lot of wrong info articles flying around. Could be planted by whales. Maybank analyst attended ADI conference and reported the following data on HMTM revealed at the conference in London.

Primary Endpint: ADAS-COG = No Decline
Primary Endpoint: ADCS-ADL = 67% slowdown in decline
Secondary Endpoint: Brain atrophy = 50% slowdown in volume shrinkage

Read the trial announcement:
"....participants receiving HMTM decline at a rate substantially less than is typical in Alzheimer’s based on published research. This was seen for both cognitive and functional endpoints across a broad range of severity from mild cognitive impairment (MCI) to moderate Alzheimer’s. Importantly, the safety profile is favourable and consistent with previous studies."

The report given by Maybank analyst who has attended ADI conference in London is consistent with what Taurx has announced. Not that I want to talk big abt Taurx.... No drugs' performance can surpass or even come anywhere near to HMTM's performance for the next 10 years. This drug is the Holy Grail for all AD patients, caregivers, doctors, govt, etc who have been waiting, praying and hoping for a miracle drug for the past few decades. HMTM will also go into the preventive AD market. Stop the disease before it starts to wreck havoc. Start the treatment early via PET scan for accumulation of toxic Tau tangles biomarkers even before physical AD symptoms appear. Huge existing AD market plus AD preventive market.

Posted by Income > 3 hours ago | Report Abuse

Nobody feels disappointed kah with Taurx results?
The results are so so only. Genting has to wait for another year.

—-
KUALA LUMPUR (March 10): Genting (GENTING, 3182, main board consumer stock) holds 20.3% of the British pharmaceutical company TauRx, in the latest Alzheimer's disease (commonly known as dementia) drug research and development report lack of breakthroughs, leading to the Shares suffered heavy losses today. Genting's share price dropped 34 sen or 6.54% to close at RM4.86 at the open this morning.
-----------------------------------------------------

This type of news need to be careful. Firstly, the date is wrong (March 10). Next, Taurx Pharmaceuticals Ltd is a Singapore company with research facilities in Aberdeen, Scotland. This is officially a 12 month trial, then open label for another 12 more months whereby the placebo patients will also take 16mg active dose after completing the official 12 month trial duration. Taurx do not need another open label extra 12 months to confirm its drug effectiveness for regulatory submissions.

Those untrue rubbish reports abt Taurx flying around on internet could be planted by whales to cause a plunge in share price. As a 0.7% shareholder of Taurx, I know this company for 18 years and they are usually conservative when making their claims.

Read the trial announcement:
"....participants receiving HMTM decline at a rate substantially less than is typical in Alzheimer’s based on published research. This was seen for both cognitive and functional endpoints across a broad range of severity from mild cognitive impairment (MCI) to moderate Alzheimer’s. Importantly, the safety profile is favourable and consistent with previous studies."

The facts are as above, it is what it is. Just wait for Taurx's official announcement for Lucidity's full trial result even though i heard of some very stunningly positive endpoint measurements data from fellow Taurx investors.

Posted by AngTayKor > 17 hours ago | Report Abuse

Posted by WinSSP > 14 minutes ago | Report Abuse

below 5 better
-------------------------------------

Of course better for professional cha cha dancers. 4 rounds of successful GenB trades this year.

Posted here last night that LKT selling his GenB shares in large volumes daily. Smart traders would have cleared their balance this morning. The dumb fake investor whose average prices can auto drop from 4.50, 4.20, 4.00, 3.50, etc can even give delusional talk abt M&A of GenB at high price.
--------------------------------

Posted by newbie2019 > 21 minutes ago | Report Abuse

ATK sifu sold ur last round last min entrance?
----------------------------------------------------

Too many fake investor's thrash posts here. I have already said I cleared.

Think I better KIV on trading this stock first. If price goes up, insider LKT will start dumping tens of millions shares. Most professional cha cha dancers dislike such scenario. Risk vs reward is not favorable.

Post removed.Why?

Posted by WinSSP > 2 hours ago | Report Abuse

Kasihan Aunty Atk….ada dementia, non-stop yapping
--------------------------------------------

Posted by WinSSP > 15 minutes ago | Report Abuse

Aunty Atk Dementia yapping non-stop. Pergi tidur la lol
---------------------------------------------


Dementia cha cha old aunty LoseSSP keep posting and deleting her previous posts. You were yapping non-stop the entire day. I only came in later. You forgot already? Cha cha old aunty's posts also has dementia, miraculously deleted, disappeared and forgotten too.

No time to poke back at fake investor old aunty liow. Watching out for my real investment Taurx's result. Cha cha cha... Jeng Jeng Jeng....